rs56035053

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_000426.4(LAMA2):​c.6161A>G​(p.Gln2054Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00117 in 1,613,994 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00096 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 2 hom. )

Consequence

LAMA2
NM_000426.4 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:7B:9O:1

Conservation

PhyloP100: 3.95
Variant links:
Genes affected
LAMA2 (HGNC:6482): (laminin subunit alpha 2) Laminin, an extracellular protein, is a major component of the basement membrane. It is thought to mediate the attachment, migration, and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. It is composed of three subunits, alpha, beta, and gamma, which are bound to each other by disulfide bonds into a cross-shaped molecule. This gene encodes the alpha 2 chain, which constitutes one of the subunits of laminin 2 (merosin) and laminin 4 (s-merosin). Mutations in this gene have been identified as the cause of congenital merosin-deficient muscular dystrophy. Two transcript variants encoding different proteins have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009768635).
BP6
Variant 6-129440891-A-G is Benign according to our data. Variant chr6-129440891-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 197478.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=4, Uncertain_significance=7, not_provided=1, Benign=1}. Variant chr6-129440891-A-G is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
LAMA2NM_000426.4 linkuse as main transcriptc.6161A>G p.Gln2054Arg missense_variant 43/65 ENST00000421865.3
LAMA2NM_001079823.2 linkuse as main transcriptc.6161A>G p.Gln2054Arg missense_variant 43/64

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
LAMA2ENST00000421865.3 linkuse as main transcriptc.6161A>G p.Gln2054Arg missense_variant 43/655 NM_000426.4
ENST00000665046.1 linkuse as main transcriptn.1337T>C non_coding_transcript_exon_variant 10/10
LAMA2ENST00000618192.5 linkuse as main transcriptc.6425A>G p.Gln2142Arg missense_variant 44/665 P1
LAMA2ENST00000617695.5 linkuse as main transcriptc.6161A>G p.Gln2054Arg missense_variant 43/645

Frequencies

GnomAD3 genomes
AF:
0.000966
AC:
147
AN:
152226
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00194
Gnomad OTH
AF:
0.000955
GnomAD3 exomes
AF:
0.000786
AC:
197
AN:
250764
Hom.:
0
AF XY:
0.000782
AC XY:
106
AN XY:
135498
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000551
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.00148
Gnomad OTH exome
AF:
0.000654
GnomAD4 exome
AF:
0.00119
AC:
1746
AN:
1461650
Hom.:
2
Cov.:
31
AF XY:
0.00114
AC XY:
827
AN XY:
727146
show subpopulations
Gnomad4 AFR exome
AF:
0.000209
Gnomad4 AMR exome
AF:
0.000649
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.0000936
Gnomad4 NFE exome
AF:
0.00148
Gnomad4 OTH exome
AF:
0.000994
GnomAD4 genome
AF:
0.000965
AC:
147
AN:
152344
Hom.:
0
Cov.:
32
AF XY:
0.000873
AC XY:
65
AN XY:
74490
show subpopulations
Gnomad4 AFR
AF:
0.000168
Gnomad4 AMR
AF:
0.000327
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00194
Gnomad4 OTH
AF:
0.000945
Alfa
AF:
0.00137
Hom.:
0
Bravo
AF:
0.00111
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00140
AC:
12
ExAC
AF:
0.000758
AC:
92
EpiCase
AF:
0.00202
EpiControl
AF:
0.00160

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:7Benign:9Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:4Benign:5
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Feb 16, 2015- -
Likely benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Uncertain significance, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsSep 29, 2015- -
Uncertain significance, criteria provided, single submitterclinical testingAthena DiagnosticsMar 30, 2020- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024LAMA2: BP4 -
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicMay 31, 2022BP4 -
Likely benign, criteria provided, single submitterclinical testingGeneDxMay 13, 2021- -
not specified Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoApr 05, 2015- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Merosin deficient congenital muscular dystrophy Uncertain:1Other:1
not provided, no classification providedphenotyping onlyGenomeConnect, ClinGen-GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsMay 23, 2017- -
Congenital muscular dystrophy due to partial LAMA2 deficiency Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsApr 12, 2022This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
LAMA2-related muscular dystrophy Benign:1
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
Intellectual disability Benign:1
Likely benign, no assertion criteria providedclinical testingCentre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de LilleJan 01, 2019- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
14
DANN
Benign
0.96
DEOGEN2
Benign
0.014
.;T;T
Eigen
Benign
-0.47
Eigen_PC
Benign
-0.33
FATHMM_MKL
Benign
0.47
N
LIST_S2
Benign
0.65
T;T;T
M_CAP
Benign
0.0049
T
MetaRNN
Benign
0.0098
T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
-0.18
.;.;N
MutationTaster
Benign
0.83
N
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.14
.;.;N
REVEL
Benign
0.058
Sift
Benign
0.43
.;.;T
Polyphen
0.0020
.;.;B
Vest4
0.17
MVP
0.59
MPC
0.097
ClinPred
0.014
T
GERP RS
3.2
Varity_R
0.076
gMVP
0.30

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs56035053; hg19: chr6-129762036; API